mailyard(SH:600107) Shang Hai Zheng Quan Bao·2025-06-09 21:11Group 1 - The company plans to sell 100% equity of its subsidiary, Qinghai Zhongyou Health Huijia Pharmaceutical Chain Co., Ltd., to Jilin Province Zhiyu Technology Co., Ltd. for a price of 100 million RMB [2] - The company has received 70 million RMB of the equity transfer payment and transferred 51% of the equity to Zhiyu Technology, but due to the failure of Zhiyu Technology to pay the remaining amount, the company has filed a lawsuit [3] - The company provided loans totaling 14.6 million RMB to Qinghai Huijia during its operation, which are to be repaid by December 31, 2024, but due to non-repayment, the company has initiated arbitration [4] Group 2 - On June 9, 2025, Zhiyu Technology paid 20 million RMB of the equity transfer payment as per the civil mediation agreement, while Qinghai Huijia paid the first installment of 3,981,842 RMB to the company [5] - The company will cooperate with Zhiyu Technology to complete the equity and business registration changes and will urge Qinghai Huijia to fulfill its remaining payment obligations as per the settlement agreement [6]